Reduced METTL14 increases circORC5 expression and lowers Akt Substrate 1S1 (AKT1S1) and Eukaryotic Translation Initiation Factor 4B (EIF4B) levels by decreasing m6A modification on circORC5, thereby accelerating gastric cancer progression. The gene discussed is EIF4B; the disease is gastric cancer.